Carole Nuechterlein
CIK 1665133 · last filed 2025-06-26
Carole Nuechterlein is a corporate insider who has filed 14 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for ALGS, was dated Jun 26, 2025. Across all open-market trades the lifetime net is +$6.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $58.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$58.22M
4
14
$6.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALGS | Director | 11,025,941 | $5.28 | $58.22M | $6.00M | 8 | 2025-06-26 |
| TRDA | Director | — | $6.46 | — | $0 | 2 | 2022-06-06 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | — | $15.90 | — | $0 | 3 | 2020-06-23 |
| AveXis, Inc. (AVXS) Delisted | Director | — | — | — | $0 | 1 | 2016-02-12 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-26 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | ALGS | Mixed | — | $0 | EDGAR |
| 2023-10-27 | ALGS | Buy (P) | +7,933,601 | $6.00M | EDGAR |
| 2023-07-21 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2021-11-01 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2020-10-20 | ALGS | Conv (C) | +3,092,340 | $0 | EDGAR |